Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
44.43
+1.13 (2.61%)
May 18, 2026, 4:00 PM EDT - Market closed
Bio-Techne Employees
Bio-Techne had 3,100 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
3,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$390,584
Profits / Employee
$35,322
Market Cap
6.96B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 3,100 | 0 | - |
| Jun 30, 2024 | 3,100 | 50 | 1.64% |
| Jun 30, 2023 | 3,050 | 50 | 1.67% |
| Jun 30, 2022 | 3,000 | 400 | 15.38% |
| Jun 30, 2021 | 2,600 | 300 | 13.04% |
| Jun 30, 2020 | 2,300 | 50 | 2.22% |
| Jun 30, 2019 | 2,250 | 250 | 12.50% |
| Jun 30, 2018 | 2,000 | 200 | 11.11% |
| Jun 30, 2017 | 1,800 | 240 | 15.38% |
| Jun 30, 2016 | 1,560 | 204 | 15.04% |
| Jun 30, 2015 | 1,356 | 335 | 32.81% |
| Jun 30, 2014 | 1,021 | 167 | 19.56% |
| Jun 30, 2013 | 854 | 7 | 0.83% |
| Jun 30, 2012 | 847 | 13 | 1.56% |
| Jun 30, 2011 | 834 | 97 | 13.16% |
| Jun 30, 2010 | 737 | -9 | -1.21% |
| Jun 30, 2009 | 746 | 27 | 3.76% |
| Jun 30, 2008 | 719 | 38 | 5.58% |
| Jun 30, 2007 | 681 | 44 | 6.91% |
| Jun 30, 2006 | 637 | 28 | 4.60% |
| Jun 30, 2005 | 609 | 12 | 2.01% |
| Jun 30, 2004 | 597 | 11 | 1.88% |
| Jun 30, 2003 | 586 | 16 | 2.81% |
| Jun 30, 2002 | 570 | 9 | 1.60% |
| Jun 30, 2001 | 561 | 64 | 12.88% |
| Jun 30, 2000 | 497 | 26 | 5.52% |
| Jun 30, 1999 | 471 | 60 | 14.60% |
| Jun 30, 1998 | 411 | 46 | 12.60% |
| Jun 30, 1997 | 365 | -7 | -1.88% |
| Jun 30, 1996 | 372 | 28 | 8.14% |
| Jun 30, 1995 | 344 | 67 | 24.19% |
| Jun 30, 1994 | 277 | 71 | 34.47% |
| Jun 30, 1993 | 206 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Corcept Therapeutics | 730 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
| Rhythm Pharmaceuticals | 414 |
| Apogee Therapeutics | 261 |
| Kymera Therapeutics | 253 |
| Nuvalent | 234 |
| Celcuity | 155 |
TECH News
- 4 days ago - Bio-Techne resumed with an Outperform at RBC Capital - TheFly
- 6 days ago - Bio-Techne Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 10 days ago - Bio-Techne price target lowered to $66 from $75 at Deutsche Bank - TheFly
- 11 days ago - Bio-Techne price target lowered to $49 from $70 at Baird - TheFly
- 11 days ago - Bio-Techne price target lowered to $50 from $65 at Stifel - TheFly
- 11 days ago - Bio-Techne price target lowered to $50 from $54 at Evercore ISI - TheFly
- 11 days ago - Bio-Techne price target lowered to $70 from $80 at Citi - TheFly
- 11 days ago - Bio-Techne price target lowered to $62 from $76 at Wells Fargo - TheFly